{
    "id": "correct_subsidiary_00047_0",
    "rank": 11,
    "data": {
        "url": "https://mergr.com/stiefel-laboratories-acquires-connetics",
        "read_more_link": "",
        "language": "en",
        "title": "Stiefel Laboratories Acquires Connetics",
        "top_image": "",
        "meta_img": "",
        "images": [
            "https://mergr.com/home/img/logo-mergr-white.svg",
            "https://mergr-image-uploads.s3.amazonaws.com/professionals/DanJanney.jpg",
            "https://mergr-image-uploads.s3.amazonaws.com/professionals/1457591547316012.jpg",
            "https://mergr-image-uploads.s3.amazonaws.com/professionals/1457591830660970.jpg",
            "https://mergr-image-uploads.s3.amazonaws.com/professionals/LarryRandall.jpg",
            "https://mergr.com/assets/member/img/glassdoor.svg",
            "https://mergr.com/home/img/logo-mergr.svg"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "On December 28, 2006, Stiefel Laboratories acquired life science company Connetics from Alta Partners",
        "meta_lang": "",
        "meta_favicon": "https://mergr.com/assets/member/img/favicon.ico",
        "meta_site_name": "",
        "canonical_link": null,
        "text": "Stiefel Laboratories, Inc. is enthusiastically committed to advancing dermatology and skin science around the world. The company’s deeply-rooted dedication and drive for innovation along with its sole focus on dermatology has led Stiefel to become the largest independent dermatology company in the world. In addition to more than 30 wholly-owned subsidiaries, six manufacturing plants and a global research and development network, Stiefel’s most valuable asset is its global network of nearly 3,500 driven associates.\n\nDEAL STATS # Overall 1 of 2 Sector (Life Science) 1 of 2 Type (Add-on Acquisition) 1 of 2 State (California) 1 of 1 Country (United States) 1 of 2 Year (2006) 1 of 1\n\nFOLLOWING DEAL\n\nDATE TARGET DEAL TYPE VALUE\n\nAlta Partners is a venture capital firm that targets investments in early and later stage life science companies, including biopharmaceuticals, medical technology, and information technology businesses. Alta was formed as an early stage investor but has since expanded its investment range to provide later stage growth capital to private and young public companies. Alta was established in 1996 and is headquartered in San Francisco, California.\n\nDEAL STATS # Overall 31 of 84 Sector (Life Science) 20 of 64 Type (Add-on Acquisition) 20 of 45 State (California) 15 of 41 Country (United States) 27 of 74 Year (2006) 6 of 6\n\nPREVIOUS DEAL\n\nDATE TARGET DEAL TYPE VALUE\n\nFOLLOWING DEAL\n\nDATE TARGET DEAL TYPE VALUE"
    }
}